Amrize Ltd $AMRZ Stock Sold by Banque Pictet & Cie SA

Key Points

• Banque Pictet & Cie SA reduced its Amrize stake by 47.4% in the third quarter, selling 56,599 shares and retaining 62,896 shares valued at approximately $2.36 million.
• Analyst sentiment is mixed, with Amrize carrying an overall “Hold” rating and a consensus price target of $50.00. Recent firms lowered targets to between $35 and $55, while the stock opened at $37.85, near its 52-week low.
• Insiders have been buying shares, including purchases by the CEO and a director; insiders acquired 48,983 shares worth about $2.16 million over the past three months. The company also recently reported quarterly EPS of $0.88, below the $0.92 consensus estimate.

Banque Pictet & Cie SA cut its holdings in shares of Amrize Ltd (NYSE:AMRZ - Free Report) by 47.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 62,896 shares of the company's stock after selling 56,599 shares during the period. Banque Pictet & Cie SA's holdings in Amrize were worth $2,363,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. Amundi grew its position in Amrize by 30.9% during the 1st quarter. Amundi now owns 1,654,739 shares of the company's stock worth $92,698,000 after purchasing an additional 390,750 shares during the period. DJE Kapital AG lifted its holdings in shares of Amrize by 45.9% in the 1st quarter. DJE Kapital AG now owns 1,113,036 shares of the company's stock valued at $60,194,000 after buying an additional 350,149 shares during the period. Great Lakes Advisors LLC acquired a new position in shares of Amrize in the 2nd quarter valued at about $16,975,000. Ancora Advisors LLC acquired a new position in shares of Amrize in the 2nd quarter valued at about $15,112,000. Finally, Assetmark Inc. lifted its holdings in shares of Amrize by 18,567.2% in the 1st quarter. Assetmark Inc. now owns 250,887 shares of the company's stock valued at $14,055,000 after buying an additional 249,543 shares during the period.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on the company. Barclays assumed coverage on Amrize in a research note on Thursday, October 1st. They issued an "equal weight" rating and a $55.00 target price on the stock. DA Davidson set a $40.00 price target on Amrize in a research report on Friday, October 9th. Bank of America reissued an "underperform" rating and issued a $40.00 price target (down from $50.00) on shares of Amrize in a report on Wednesday, September 2nd. Truist Financial decreased their price target on Amrize from $48.00 to $35.00 and set a "hold" rating for the company in a report on Monday, October 5th. Finally, Oppenheimer lowered their price objective on Amrize from $62.00 to $55.00 and set an "outperform" rating on the stock in a research report on Friday, September 18th. One research analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, seven have issued a Hold rating and four have given a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $50.00.

Insider Activity

In other Amrize news, Director Jacques Sanche purchased 4,150 shares of Amrize stock in a transaction that occurred on Wednesday, August 26th. The stock was bought at an average price of $45.02 per share, with a total value of $186,833.00. Following the acquisition, the director owned 9,766 shares of the company's stock, valued at $439,665.32. This trade represents a 73.90% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Jan Jenisch purchased 4,000 shares of Amrize stock in a transaction that occurred on Wednesday, September 2nd. The stock was acquired at an average cost of $42.50 per share, with a total value of $170,000.00. Following the acquisition, the chief executive officer directly owned 519,000 shares in the company, valued at $22,057,500. This trade represents a 0.78% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders acquired 48,983 shares of company stock worth $2,158,755. 0.54% of the stock is currently owned by corporate insiders.

Amrize Stock Up 1.4%

AMRZ stock opened at $37.85 on Friday. The firm has a market cap of $20.94 billion, a PE ratio of 17.44, a P/E/G ratio of 1.34 and a beta of 0.20. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.73 and a current ratio of 1.10. The firm's fifty day moving average is $40.94 and its 200 day moving average is $48.83. Amrize Ltd has a one year low of $35.78 and a one year high of $65.94.

Amrize (NYSE:AMRZ - Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts' consensus estimates of $0.92 by ($0.04). The firm had revenue of $3.49 billion during the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. On average, research analysts forecast that Amrize Ltd will post 2.44 EPS for the current year.

Amrize Dividend Announcement

The firm also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date was Tuesday, August 18th. Amrize's dividend payout ratio (DPR) is 5.07%.

Amrize Profile

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim's North American business and began operating as an independent, publicly traded company in 2025.

Want to see what other hedge funds are holding AMRZ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amrize Ltd (NYSE:AMRZ - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.